Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,607.90
20.32
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,953.22
0.19%
3.25

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.08
4.85
4.80

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.76
6.04
7.24

PAT CAGR (%)

10 Years
5 Years
3 Years

12.23
7.34
11.65

P:E (Median)

8 Years
5 Years
3 Years

26.92
32.96
25.65

P:BV (Average)

8 Years
5 Years
3 Years

4.05
4.22
3.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.85
22.20
17.96

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 216.64 154.58 40.15% 197.93 171.02 15.74% 216.93 157.17 38.02% 236.53 155.51 52.10%
Expenses 139.05 115.56 20.33% 148.66 132.42 12.26% 140.12 127.97 9.49% 165.58 107.23 54.42%
EBITDA 77.59 39.02 98.85% 49.28 38.60 27.67% 76.81 29.20 163.05% 70.95 48.29 46.92%
EBIDTM 35.81% 25.24% -0.29% 22.57% 35.41% 18.58% 30.00% 31.05%
Other Income 2.64 3.46 -23.70% 2.97 3.56 -16.57% 2.47 4.33 -42.96% 2.45 3.94 -37.82%
Interest 3.54 1.32 168.18% 1.29 1.10 17.27% 1.09 0.96 13.54% 0.63 0.33 90.91%
Depreciation 9.91 9.46 4.76% 9.16 9.21 -0.54% 9.52 10.03 -5.08% 9.45 8.80 7.39%
PBT 119.72 31.70 277.67% 37.26 23.87 56.10% 68.66 16.79 308.93% 63.32 63.03 0.46%
Tax 33.58 5.59 500.72% 11.89 7.17 65.83% 12.05 1.12 975.89% 10.22 14.01 -27.05%
PAT 86.14 26.10 230.04% 25.36 16.70 51.86% 56.61 15.67 261.26% 53.10 49.03 8.30%
PATM 39.76% 16.89% 2.87% 9.77% 26.10% 9.97% 22.45% 31.53%
EPS 10.57 3.20 230.31% 3.11 2.05 51.71% 6.95 1.92 261.98% 6.51 6.02 8.14%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 222.87 160.99 38.44% 219.99 199.52 10.26% 236.85 173.43 36.57% 289.92 162.28 78.65%
Expenses 157.11 132.19 18.85% 174.40 162.11 7.58% 163.11 147.25 10.77% 221.91 124.75 77.88%
EBITDA 65.75 28.80 128.30% 45.60 37.40 21.93% 73.74 26.18 181.67% 68.00 37.53 81.19%
EBIDTM 29.50% 17.89% 14.01% 18.75% 31.13% 15.09% 23.46% 23.13%
Other Income 5.48 1.98 176.77% 8.91 3.09 188.35% 3.25 3.13 3.83% 5.82 3.15 84.76%
Interest 4.00 1.46 173.97% 1.01 1.41 -28.37% 1.27 1.07 18.69% 0.82 0.63 30.16%
Depreciation 12.33 10.66 15.67% 11.55 10.54 9.58% 10.97 11.25 -2.49% 10.66 10.00 6.60%
PBT 115.74 18.66 520.26% 41.57 28.09 47.99% 64.76 11.24 476.16% 62.34 56.12 11.08%
Tax 29.14 4.05 619.51% 7.55 5.61 34.58% 10.53 -0.46 - 11.18 11.39 -1.84%
PAT 86.60 14.61 492.74% 34.02 22.49 51.27% 54.24 11.70 363.59% 51.16 44.73 14.38%
PATM 38.86% 9.07% 7.11% 11.27% 22.90% 6.75% 17.65% 27.56%
EPS 10.63 1.79 493.85% 4.17 2.76 51.09% 6.65 1.44 361.81% 6.28 5.49 14.39%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 868.03 805.97 663.88 741.29 733.67 675.79 565.40 527.37 328.20 279.76 257.54 Net Sales Growth 36.00% 21.40% -10.44% 1.04% 8.56% 19.52% 7.21% 60.69% 17.31% 8.63% Cost Of Goods Sold 710.82 258.38 229.62 348.45 365.75 359.49 309.52 305.03 205.00 174.56 153.87 Gross Profit 157.21 547.60 434.26 392.85 367.92 316.30 255.88 222.34 123.19 105.20 103.67 GP Margin 18.11% 67.94% 65.41% 53.00% 50.15% 46.80% 45.26% 42.16% 37.54% 37.60% 40.25% Total Expenditure 593.41 568.18 491.85 573.43 560.97 511.35 431.01 409.65 262.79 223.47 188.15 Power & Fuel Cost - 35.31 31.63 27.00 24.56 20.54 17.58 15.55 8.83 7.63 5.65 % Of Sales - 4.38% 4.76% 3.64% 3.35% 3.04% 3.11% 2.95% 2.69% 2.73% 2.19% Employee Cost - 149.28 136.22 113.29 91.53 67.27 56.49 42.13 22.76 16.94 12.85 % Of Sales - 18.52% 20.52% 15.28% 12.48% 9.95% 9.99% 7.99% 6.93% 6.06% 4.99% Manufacturing Exp. - 75.34 57.85 55.48 50.58 42.10 29.78 22.80 13.28 10.20 7.83 % Of Sales - 9.35% 8.71% 7.48% 6.89% 6.23% 5.27% 4.32% 4.05% 3.65% 3.04% General & Admin Exp. - 24.76 16.73 12.15 11.52 9.00 6.57 6.41 7.67 6.45 4.02 % Of Sales - 3.07% 2.52% 1.64% 1.57% 1.33% 1.16% 1.22% 2.34% 2.31% 1.56% Selling & Distn. Exp. - 10.04 6.51 6.00 4.51 7.24 5.83 7.22 4.11 3.03 2.84 % Of Sales - 1.25% 0.98% 0.81% 0.61% 1.07% 1.03% 1.37% 1.25% 1.08% 1.10% Miscellaneous Exp. - 15.07 13.29 11.06 12.52 5.71 5.25 10.51 1.12 4.67 2.84 % Of Sales - 1.87% 2.00% 1.49% 1.71% 0.84% 0.93% 1.99% 0.34% 1.67% 0.42% EBITDA 274.63 237.79 172.03 167.86 172.70 164.44 134.39 117.72 65.41 56.29 69.39 EBITDA Margin 31.64% 29.50% 25.91% 22.64% 23.54% 24.33% 23.77% 22.32% 19.93% 20.12% 26.94% Other Income 10.53 40.02 17.41 34.52 29.82 11.14 7.51 8.85 5.01 7.79 9.10 Interest 6.55 4.33 2.89 2.12 2.79 3.27 3.88 3.40 1.95 1.97 2.27 Depreciation 38.04 34.96 37.17 32.78 26.66 21.19 19.09 21.09 12.75 11.44 10.42 PBT 288.96 238.53 149.37 167.49 173.08 151.12 118.93 102.08 55.72 50.66 65.79 Tax 67.74 40.27 31.49 34.25 41.09 35.84 34.84 21.23 9.65 11.54 14.91 Tax Rate 23.44% 17.21% 20.24% 20.45% 24.38% 24.10% 29.29% 20.80% 17.35% 22.50% 22.66% PAT 221.21 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 PAT before Minority Interest 221.21 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.48% 24.04% 18.69% 17.97% 17.37% 16.70% 14.87% 15.33% 14.00% 14.21% 19.76% PAT Growth 105.78% 56.09% -6.85% 4.54% 12.93% 34.20% 4.01% 75.94% 15.62% -21.88% EPS 27.14 23.77 15.23 16.35 15.64 13.85 10.32 9.92 5.64 4.88 6.24

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 969.63 907.91 733.39 788.83 779.16 716.43 613.80 571.38 371.32 318.18 290.29 Net Sales Growth 39.27% 23.80% -7.03% 1.24% 8.76% 16.72% 7.42% 53.88% 16.70% 9.61% Cost Of Goods Sold 4,864.24 277.73 256.57 355.87 371.81 366.19 323.16 313.26 213.95 183.22 162.98 Gross Profit -3,894.61 630.18 476.81 432.95 407.36 350.25 290.63 258.12 157.38 134.96 127.31 GP Margin -401.66% 69.41% 65.01% 54.89% 52.28% 48.89% 47.35% 45.17% 42.38% 42.42% 43.86% Total Expenditure 716.53 693.39 579.40 637.60 617.55 556.44 487.38 455.40 301.63 257.08 219.70 Power & Fuel Cost - 38.76 33.55 28.86 26.30 21.90 19.29 17.37 10.67 9.38 7.03 % Of Sales - 4.27% 4.57% 3.66% 3.38% 3.06% 3.14% 3.04% 2.87% 2.95% 2.42% Employee Cost - 196.59 176.40 149.35 127.87 90.09 82.30 67.83 42.56 33.68 28.37 % Of Sales - 21.65% 24.05% 18.93% 16.41% 12.57% 13.41% 11.87% 11.46% 10.59% 9.77% Manufacturing Exp. - 79.19 60.96 59.96 52.55 45.35 36.55 27.44 16.92 12.89 8.35 % Of Sales - 8.72% 8.31% 7.60% 6.74% 6.33% 5.95% 4.80% 4.56% 4.05% 2.88% General & Admin Exp. - 70.26 27.05 22.50 16.95 14.11 10.64 9.53 9.51 7.87 5.64 % Of Sales - 7.74% 3.69% 2.85% 2.18% 1.97% 1.73% 1.67% 2.56% 2.47% 1.94% Selling & Distn. Exp. - 10.40 6.66 6.37 4.75 7.27 5.99 7.29 4.43 3.19 4.63 % Of Sales - 1.15% 0.91% 0.81% 0.61% 1.01% 0.98% 1.28% 1.19% 1.00% 1.59% Miscellaneous Exp. - 20.47 18.20 14.68 17.32 11.54 9.45 12.68 3.59 6.86 4.63 % Of Sales - 2.25% 2.48% 1.86% 2.22% 1.61% 1.54% 2.22% 0.97% 2.16% 0.93% EBITDA 253.09 214.52 153.99 151.23 161.61 159.99 126.42 115.98 69.69 61.10 70.59 EBITDA Margin 26.10% 23.63% 21.00% 19.17% 20.74% 22.33% 20.60% 20.30% 18.77% 19.20% 24.32% Other Income 23.46 22.22 15.57 32.62 29.34 11.36 6.93 9.12 5.01 8.28 8.95 Interest 7.10 4.56 3.68 2.66 3.13 3.93 4.05 3.52 2.27 2.31 2.63 Depreciation 45.51 43.78 42.06 37.22 30.64 23.14 21.41 23.22 15.34 14.36 12.96 PBT 284.41 188.40 123.82 143.96 157.17 144.28 107.89 98.35 57.10 52.71 63.95 Tax 58.40 33.49 26.18 33.91 42.04 35.62 35.22 20.30 9.53 12.22 14.60 Tax Rate 20.53% 17.78% 18.22% 23.56% 27.54% 25.11% 32.66% 21.27% 16.72% 22.91% 22.83% PAT 226.02 156.50 120.28 112.43 113.71 109.84 73.69 75.67 47.35 41.23 49.35 PAT before Minority Interest 226.79 154.91 117.52 110.05 110.59 106.24 72.62 75.15 47.47 41.11 49.35 Minority Interest 0.77 1.59 2.76 2.38 3.12 3.60 1.07 0.52 -0.12 0.12 0.00 PAT Margin 23.31% 17.24% 16.40% 14.25% 14.59% 15.33% 12.01% 13.24% 12.75% 12.96% 17.00% PAT Growth 141.66% 30.11% 6.98% -1.13% 3.52% 49.06% -2.62% 59.81% 14.84% -16.45% EPS 27.73 19.20 14.76 13.80 13.95 13.48 9.04 9.28 5.81 5.06 6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,453.42 1,281.55 1,156.98 1,029.62 664.59 563.10 412.56 330.79 287.30 235.21 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,445.27 1,273.39 1,148.83 1,021.60 656.88 555.39 405.21 325.88 282.39 226.03 Non-Current Liabilities 208.00 157.15 139.08 241.14 59.29 59.43 65.23 64.16 24.94 27.02 Secured Loans 164.48 80.39 67.08 141.18 0.00 16.23 37.38 43.22 5.07 11.16 Unsecured Loans 0.00 0.70 1.03 1.30 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.72 5.36 5.08 5.55 4.32 3.89 0.88 0.31 0.76 0.60 Current Liabilities 359.86 229.59 251.05 219.71 205.32 160.13 149.05 111.97 109.74 68.37 Trade Payables 76.63 71.37 98.86 103.91 98.20 65.58 86.61 47.74 53.13 24.00 Other Current Liabilities 119.85 76.53 56.68 25.20 25.74 38.28 35.64 21.51 18.28 14.27 Short Term Borrowings 156.40 78.72 92.95 88.04 69.59 50.84 22.02 38.92 35.73 27.86 Short Term Provisions 6.97 2.97 2.57 2.55 11.79 5.43 4.78 3.80 2.60 2.24 Total Liabilities 2,021.28 1,668.29 1,547.11 1,490.47 929.20 782.66 626.84 506.92 421.98 330.60 Net Block 517.00 510.84 488.69 448.85 349.77 280.01 257.66 152.56 140.84 127.09 Gross Block 756.00 723.32 666.58 594.31 469.21 378.74 338.75 212.70 188.18 163.00 Accumulated Depreciation 238.99 212.49 177.89 145.46 119.44 98.73 81.09 60.14 47.34 35.90 Non Current Assets 1,113.59 1,147.87 893.90 786.14 597.17 497.66 402.49 324.23 246.74 159.19 Capital Work in Progress 372.81 401.21 200.99 136.51 89.38 87.71 49.24 114.27 55.27 1.25 Non Current Investment 93.48 89.04 111.35 101.78 94.05 74.24 65.07 37.01 33.11 28.08 Long Term Loans & Adv. 124.54 119.95 68.04 94.26 58.65 55.60 30.48 19.99 17.18 2.46 Other Non Current Assets 5.76 26.83 24.83 4.75 5.31 0.08 0.05 0.40 0.34 0.30 Current Assets 907.69 520.42 653.22 704.32 332.03 284.99 224.36 182.69 175.24 171.41 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 206.23 176.70 167.72 174.96 124.66 120.88 108.95 66.13 59.87 37.44 Sundry Debtors 226.54 181.68 218.14 166.50 111.98 70.12 60.31 31.88 33.19 33.63 Cash & Bank 28.19 90.93 73.14 93.10 5.66 2.49 0.81 10.53 1.95 83.75 Other Current Assets 446.73 55.40 28.59 23.24 30.11 26.15 44.15 23.87 12.22 16.59 Short Term Loans & Adv. 30.17 15.70 46.09 21.91 15.56 4.95 26.77 12.66 5.71 10.51 Net Current Assets 547.83 290.83 402.16 484.62 126.71 124.87 75.31 70.72 65.50 103.04 Total Assets 2,021.28 1,668.29 1,547.12 1,490.46 929.20 782.65 626.85 506.92 421.98 330.60

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,329.36 1,197.58 1,085.03 986.90 639.26 546.94 396.45 320.42 275.98 224.68 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,321.21 1,189.43 1,076.88 978.88 631.55 539.23 389.09 315.52 271.07 213.85 Non-Current Liabilities 256.94 166.62 153.48 251.26 67.23 154.15 104.53 98.51 31.13 31.85 Secured Loans 164.48 80.39 67.09 141.20 0.03 71.03 37.43 70.47 5.07 11.42 Unsecured Loans 0.53 0.70 1.03 1.30 0.00 31.30 30.05 0.00 0.00 0.00 Long Term Provisions 26.17 21.77 20.32 16.89 13.96 11.75 9.93 6.92 6.34 5.71 Current Liabilities 407.74 253.54 265.84 236.90 222.07 189.06 166.84 123.77 121.14 80.21 Trade Payables 89.46 82.58 103.74 111.86 106.48 75.50 92.98 51.26 56.72 27.90 Other Current Liabilities 142.11 79.86 59.59 28.03 36.49 49.32 38.23 23.38 20.34 16.65 Short Term Borrowings 165.27 86.58 98.12 92.41 74.10 58.47 30.27 45.07 41.24 33.15 Short Term Provisions 10.90 4.52 4.39 4.60 5.00 5.77 5.37 4.06 2.83 2.51 Total Liabilities 1,986.13 1,610.12 1,499.13 1,472.22 930.89 904.54 677.83 551.42 433.11 338.21 Net Block 650.44 558.01 534.20 491.93 393.41 316.06 294.42 180.67 166.61 146.25 Gross Block 986.42 853.16 793.24 704.89 582.20 476.34 448.38 300.89 271.30 232.84 Accumulated Depreciation 335.98 295.15 259.04 212.96 188.79 160.28 153.96 120.22 104.70 86.59 Non Current Assets 1,365.35 1,064.96 827.16 742.33 576.68 576.77 443.89 339.18 244.95 159.79 Capital Work in Progress 666.25 429.12 209.85 140.51 91.90 221.62 111.03 129.15 57.71 2.72 Non Current Investment 10.45 2.25 20.79 27.99 34.15 0.19 0.21 0.14 0.11 3.65 Long Term Loans & Adv. 32.42 48.75 37.47 77.09 51.86 38.74 38.18 28.82 20.17 6.62 Other Non Current Assets 5.78 26.84 24.86 4.80 5.36 0.16 0.06 0.40 0.34 0.00 Current Assets 620.78 545.16 671.97 729.88 354.21 327.61 233.74 211.99 187.87 178.39 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 226.43 187.67 188.71 190.00 134.23 130.78 123.25 74.33 67.32 43.33 Sundry Debtors 243.72 203.73 220.27 170.93 125.43 81.37 67.96 41.79 40.53 40.13 Cash & Bank 44.56 94.54 73.83 100.39 11.03 18.42 9.19 16.87 2.27 87.20 Other Current Assets 106.06 45.04 26.08 22.00 23.90 31.69 23.20 28.72 9.72 7.72 Short Term Loans & Adv. 29.25 14.18 43.54 21.95 8.90 4.91 3.23 2.86 3.01 1.56 Net Current Assets 213.04 291.62 406.13 492.98 132.14 138.55 66.90 88.22 66.73 98.18 Total Assets 1,986.13 1,610.12 1,499.13 1,472.21 930.89 904.54 677.83 551.42 433.10 338.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 129.79 127.24 54.46 50.49 119.65 67.35 58.99 35.95 49.57 32.44 PBT 233.99 155.60 167.49 168.53 148.70 118.93 102.08 55.61 51.29 65.84 Adjustment -5.39 23.58 8.68 15.28 18.05 22.61 16.42 8.34 7.28 6.66 Changes in Working Capital -57.95 -16.48 -81.25 -99.93 -15.54 -49.19 -38.22 -17.11 -1.22 -27.41 Cash after chg. in Working capital 170.65 162.69 94.92 83.89 151.21 92.35 80.29 46.84 57.35 45.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -40.85 -35.45 -40.45 -33.40 -31.55 -25.01 -21.30 -10.89 -7.78 -12.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -295.08 -177.79 -12.83 -274.78 -100.98 -139.48 -38.20 -63.04 -144.57 -9.02 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -286.36 -62.68 28.41 70.17 5.25 3.36 10.74 6.64 7.68 20.60 Cash from Financing Activity 170.10 8.17 -61.16 315.27 -14.58 73.82 -30.51 35.67 12.99 58.24 Net Cash Inflow / Outflow 4.82 -42.38 -19.53 90.98 4.09 1.69 -9.72 8.58 -82.01 81.66 Opening Cash & Equivalents 30.76 73.14 92.68 1.70 -3.02 0.81 10.53 1.95 83.96 2.09 Closing Cash & Equivalent 28.19 30.76 73.14 92.68 1.07 2.49 0.81 10.53 1.95 83.75

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 123.72 138.76 44.92 37.48 128.70 68.81 70.04 43.64 56.73 40.86 PBT 188.40 135.68 136.77 146.49 140.36 107.84 95.45 57.00 53.51 64.13 Adjustment 41.32 20.44 18.83 17.19 20.61 26.46 19.62 11.52 10.19 10.42 Changes in Working Capital -63.80 18.71 -69.66 -92.61 -2.70 -40.11 -23.44 -13.90 0.77 -21.04 Cash after chg. in Working capital 165.92 174.83 85.94 71.08 158.27 94.19 91.62 54.62 64.46 53.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.20 -36.07 -41.02 -33.60 -29.56 -25.38 -21.58 -10.98 -7.73 -12.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -288.85 -188.15 -8.76 -262.23 -109.20 -195.18 -48.93 -95.21 -152.31 7.77 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -280.13 -73.04 32.48 82.72 -2.97 -52.34 0.01 -25.53 -0.06 37.39 Cash from Financing Activity 175.50 10.06 -60.91 312.70 -19.65 135.05 -28.34 66.31 10.02 35.93 Net Cash Inflow / Outflow 10.38 -39.32 -24.75 87.95 -0.15 8.68 -7.23 14.74 -85.56 84.56 Opening Cash & Equivalents 34.36 73.83 99.97 7.05 3.61 9.19 16.87 2.27 87.83 2.65 Closing Cash & Equivalent 44.56 34.36 73.83 99.97 6.43 18.42 9.19 16.87 2.27 87.20

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 178.28 157.19 141.91 128.50 86.20 73.03 112.15 89.92 78.10 64.06 ROA 10.50% 7.72% 8.77% 10.53% 13.19% 11.93% 14.26% 9.90% 10.56% 17.77% ROE 14.17% 10.18% 12.19% 15.05% 18.39% 17.24% 21.75% 14.87% 15.34% 29.67% ROCE 14.44% 11.28% 13.00% 16.98% 21.70% 21.49% 22.89% 14.93% 16.97% 29.19% Fixed Asset Turnover 1.09 0.96 1.18 1.39 1.61 1.59 1.94 1.67 1.62 1.65 Receivable days 92.44 109.91 94.36 68.87 48.77 41.69 31.48 35.42 42.78 45.13 Inventory Days 86.71 94.68 84.06 74.10 65.76 73.47 59.79 68.58 62.31 56.19 Payable days 46.77 60.70 63.90 61.73 57.90 62.98 59.11 68.15 62.12 57.27 Cash Conversion Cycle 132.38 143.89 114.52 81.24 56.63 52.19 32.17 35.85 42.98 44.05 Total Debt/Equity 0.26 0.15 0.16 0.23 0.13 0.15 0.19 0.30 0.19 0.22 Interest Cover 55.05 54.78 79.92 61.31 46.45 31.65 31.05 29.59 27.03 29.94

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 163.06 146.89 133.09 123.17 82.91 70.92 107.72 43.52 74.94 60.67 ROA 8.62% 7.56% 7.41% 9.20% 11.58% 9.18% 12.23% 9.64% 10.66% 16.84% ROE 12.26% 10.30% 10.62% 13.60% 17.92% 15.40% 20.98% 15.93% 16.63% 30.96% ROCE 12.41% 11.05% 11.71% 15.91% 19.90% 17.90% 20.48% 15.04% 18.02% 28.98% Fixed Asset Turnover 0.99 0.89 1.06 1.22 1.36 1.34 1.54 1.32 1.28 1.30 Receivable days 89.94 105.51 90.20 69.00 52.26 43.99 34.62 39.70 45.47 46.24 Inventory Days 83.24 93.66 87.32 75.49 66.97 74.84 62.33 68.31 62.38 57.79 Payable days 46.83 58.66 61.51 60.89 60.10 62.86 57.06 63.94 59.10 55.44 Cash Conversion Cycle 126.35 140.51 116.00 83.61 59.13 55.97 39.90 44.07 48.76 48.59 Total Debt/Equity 0.29 0.16 0.18 0.24 0.14 0.34 0.30 0.41 0.22 0.26 Interest Cover 42.34 40.09 55.10 49.69 37.07 27.63 28.09 26.13 24.13 25.28

Top Investors:

tano maurtius india fvci ii

baring india private equity fund iii limited

ta fii investors limited

pivotal enterprises private limited

barclays merchant bank (singapore) limited - odi

amal n parekh

duro one investments limited

baring india private equity fund iii listed invest

pivotal business managers llp

iepf

Annual Reports:

News Update:

Shilpa Medicare gets nod to establish whole owned subsidiary in Malaysia
18th Sep 2020, 14:40 PM

The Board of Directors of the company at its meeting held on September 18, 2020 approved the same
Read More
Shilpa Medicare forays into OTC segment
25th Aug 2020, 09:29 AM

The company has forayed into OTC segment with the launch of ready-to-drink green tea films
Read More
Shilpa Medicare reports 5-fold jump in Q1 consolidated net profit
10th Aug 2020, 10:55 AM

Total consolidated income of the company increased by 40.12% at Rs 228.35 crore for Q1FY21
Read More
Shilpa Medicare - Quarterly Results
8th Aug 2020, 18:16 PM

Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: